Form 4 for GILD Gilead Sciences
Accepted 2024-11-27 00:00:00 ET · period of report 2024-11-26 · accession 0001127602-24-028213 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-11-27 | 2024-11-26 | GILD | Bluestone Jeffrey | Dir | S - Sale+OE | $91.39 | -6,788 | 8,920 | -43% | -$620.4K |
| DM | 2024-11-27 | 2024-11-26 | GILD | Bluestone Jeffrey | Dir | M - OptEx | $61.24 | +10.0K | 11.6K | +630% | +$612.4K |
| DM | 2024-11-27 | 2024-11-26 | GILD | Bluestone Jeffrey | Dir | M - OptEx | $0.00 | -10.0K | 11.7K | -46% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-11-26 | S | D | 6,788 | $91.39 | 8,920 | D | — | — | (F1) Sale prices reported for the transactions reported here range from $91.3901 to $91.3910. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request. |
| 2 | Common | Common Stock | 2024-11-26 | M | A | 4,121 | $61.35 | 15,708 | D | — | — | |
| 3 | Common | Common Stock | 2024-11-26 | M | A | 5,879 | $61.17 | 11,587 | D | — | — | |
| 4 | Derivative | Non-qualified Stock Option (Right to Buy) | 2024-11-26 | M | D | 5,879 | $0.00 | 0 | D | $61.17 · — to 2030-12-08 | 5,879 Common Stock | (F2) 25% of the shares subject to the option vest on each three-month anniversary measured from December 8, 2020 such that 100% of the shares subject to the option will be fully vested and exercisable on December 8, 2021. |
| 5 | Derivative | Non-qualified Stock Option (Right to Buy) | 2024-11-26 | M | D | 4,121 | $0.00 | 11,730 | D | $61.35 · — to 2032-05-05 | 4,121 Common Stock | (F3) 100% of the shares subject to the stock option vested immediately upon the grant date of May 5, 2022. |